Search
Boston Scientific Corp
BSXAdd to Watchlist
49.310USD
+0.010+0.02%
Close 08-07 16:00（ET）Quotes delayed by 15 min
73.29BMarket Cap
20.51P/E TTM
Forecast
Currency: USD Updated: 2026-08-07The current earnings forecast score of Boston Scientific Corp is 8.29, ranking 53 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 127.00, with a high of 140.00 and a low of 101.45.
Analyst Rating
Based on
34
analysts
Buy
Current Rating
65.376
Target Price
+33.18%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
88
Total
4
Median
7
Average
Company name
Ratings
Analysts
Boston Scientific Corp
BSX
34
Intuitive Surgical Inc
ISRG
34
Edwards Lifesciences Corp
EW
32
Thermo Fisher Scientific Inc
TMO
32
Veeva Systems Inc
VEEV
30
Danaher Corp
DHR
28
1
2
3
...
18
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Boston Scientific Corp's expected revenue for the next quarter?
Boston Scientific Corp's expected revenue is 5.25B.
What is Boston Scientific Corp's price target?
Analysts forecast that Boston Scientific Corp's price target is USD 127.00, with the highest forecast at USD 140.00 and the lowest forecast at USD 101.45.
How have Boston Scientific CorpBSX's recent earnings per share performed?
The market expectation was USD 0.62, while Boston Scientific CorpBSX's earnings per share (EPS) for the previous quarter was USD 0.90. EPS for the next quarter is expected at USD 0.81.
What is the analyst rating for Boston Scientific Corp?
Based on the ratings of Boston Scientific Corp's stock from 34 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.